Cytori Therapeutics Inc Stock Analysis
Technical stock analysis for Tue 11'th Dec 2018
Cytori Therapeutics Inc fell by -2.09% in the last day from $0.32 to $0.31 and has now fallen 6 days in a row. The price has fallen in 7 of the last 10 days and is down by -5.38% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -160 968 shares and in total 76 900 shares bought and sold for approximately $24 092.80.
Cytori Therapeutics Inc lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -29.61% during the next 3 months and, with 90% probability hold a price between $0.18 and $0.25 at the end of this period.
There are few to none technical positive signals at the moment. Cytori Therapeutics Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.33 and $0.34. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Monday December 03, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 39 and the stock is currently not being overbought or oversold
Support & Resistance
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Cytori Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
|CYTX $0.31 $-0.01(-2.09%)|
CYTX is down $0.01 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for CYTX based on the 1-3 month system that more than doubles the S&P 500.
Click here – the CYTX analysis is free »